Adverse Drug Reaction Markup Language

Other names: EU-ADR ML

The Adverse Drug Reaction Markup Language (EU-ADR ML) was created to as part of the EU-ADR project. The ultimate aim of this project was to develop an innovative approach to the early detection of adverse drug reactions. The status of this format is uncertain as FAIRsharing cannot find documentation for the format itself beyond what is available in this record.




adverse reaction disease drug electronic health record target

More to explore:


Need help integrating and/or managing biomedical data?